FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing an optically active chromene oxide compound of formula or formula where R5, R6, R7, R8, R9, R10 and A are as described in the claim, and the absolute configuration of carbon atoms, denoted by *, denotes (R) or (S), which includes asymmetric epoxidation of a chromene compound of formula or formula with an oxidant in a solvent using optically active titanium complexes of formula formula formula and formula where R1, R2, R3 and R4 are defined in the claim, as a catalyst for asymmetric oxidation of the optically active chromene compound with high enantioselectivity and high chemical output.
EFFECT: efficient method of producing an optically active chromene oxide compound, which is an important intermediate compound used to produce a benzopyran compound, which is effective in treating arrhythmia.
18 cl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED DIHYDROQUINAZOLINES HAVING ANTIVIRAL PROPERTIES | 2004 |
|
RU2360912C2 |
NOVEL PIPERAZINE COMPOUND AND USE THEREOF AS HCV POLYMERASE INHIBITOR | 2007 |
|
RU2412171C2 |
AGENTS AGAINST FEEBLE-MINDEDNESS COMPRISING DERIVATIVES OF 2-ARYL-8-OXODIHYDROPURINE AS ACTIVE COMPONENT | 2001 |
|
RU2277096C2 |
DERIVATIVES OF 4-AMINOBENZOPYRANE | 2002 |
|
RU2288226C2 |
DERIVATIVES OF AMINOQUINOLINE AND THEIR USING AS ADENOSINE A3 LIGANDS | 2004 |
|
RU2317290C2 |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
3-ETHYLIDENEHYDRAZINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | 2005 |
|
RU2395505C2 |
METHOD FOR PREPARING HERBICIDE DERIVATIVES AND INTERMEDIATE COMPOUND | 2000 |
|
RU2244715C2 |
USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
Authors
Dates
2012-04-20—Published
2007-03-09—Filed